NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/16/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization16.87 mln
Float8.04 mln
Earnings Date11/05/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
97
/ 100
Top performer
ROE
-898
Deeply negative
ROA
-256
Deeply negative
Business Description
Tempest Therapeutics is a California-based company focused on developing oral drugs designed to fight cancer. Its two main treatment candidates target specific biological pathways involved in tumor growth, with one aimed at a hard-to-treat form of liver cancer and the other being tested across multiple cancer types. The company is working with global pharmaceutical company Roche to advance its liver cancer drug through a large international clinical trial.
